{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:16:27Z","timestamp":1789208187619,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jconrel.2015.01.035","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T17:42:09Z","timestamp":1422466929000},"page":"65-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Potential of nanotechnology as a delivery platform against tuberculosis: Current research review"],"prefix":"10.1016","volume":"202","author":[{"given":"S.","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Kusum Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.01.035_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1538-5442(01)70040-5","article-title":"Tuberculosis in children","author":"Smith","year":"2001","journal-title":"Curr. Probl. Pediatr."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0010","doi-asserted-by":"crossref","first-page":"9885","DOI":"10.1021\/ja072892+","article-title":"Synthesis of the docosanasaccharide arabinan domain of mycobacterial arabinogalactan and a proposed octadecasaccharide biosynthetic precursor","volume":"129","author":"Joe","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2015.01.035_rf0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1465-9921-7-118","article-title":"Tuberculosis chemotherapy: current drug delivery approaches","volume":"7","author":"Toit","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0020","series-title":"Division of Tuberculosis Elimination Report\u20142012","year":"2012"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.18433\/J3M59P","article-title":"Present Status of Nanoparticle Research for Treatment of Tuberculosis","volume":"14","author":"Shegokar","year":"2011","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0030","series-title":"Nanoparticulate Drug-Delivery Systems: An Overview","author":"Thassu","year":"2000"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0035","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijantimicag.2005.07.012","article-title":"Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis","volume":"26","author":"Zahoor","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0040","series-title":"Global TB Report-2013","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.jconrel.2015.01.035_rf0340","series-title":"Revised National TB Control Programme (RNTCP) Annual Report\u20142013, Central TB Division (CTD)","year":"2013"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0050","series-title":"India \u2014 Tuberculosis Profile\u20142014","year":"2014"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0055","series-title":"Multidrug-resistant Tuberculosis (MDR-TB) \u2014 2013 Update","year":"2013"},{"key":"10.1016\/j.jconrel.2015.01.035_rf0355","series-title":"Treatment of Tuberculosis Guidelines","first-page":"1","author":"Royce","year":"2009"},{"key":"10.1016\/j.jconrel.2015.01.035_rf0360","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1164\/rccm.200504-613PP","article-title":"The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis","volume":"172","author":"Gelperina","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0070","first-page":"255","article-title":"Encapsulation, characterization and in-vitro release of anti-tuberculosis drug using chitosan-polyethylene glycol nanoparticles","volume":"4","author":"Rajan","year":"2012","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0075","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tube.2005.08.009","article-title":"Oral solid lipid nanoparticle-based antitubercular chemotherapy","volume":"85","author":"Pandey","year":"2005","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0169-409X(00)00124-1","article-title":"Block copolymer micelles for drug delivery: design, characterization and biological significance","volume":"74","author":"Kataoka","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.01.035_rf0060","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.progpolymsci.2005.01.007","article-title":"Birth of new molecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry","volume":"30","author":"Tomalia","year":"2005","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2015.01.035_rf0065","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1021\/nl052396o","article-title":"Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells","volume":"6","author":"Chithrani","year":"2006","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0095","first-page":"1","article-title":"Antituberculous effect of silver nanoparticles","volume":"291","author":"Kreytsberg","year":"2011","journal-title":"J. Phys. Conf. Ser. Nanotechnol. Int. Forum"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0100","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","article-title":"Nanosuspensions in drug delivery","volume":"3","author":"Rabinow","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0105","first-page":"1","article-title":"Potential of targeted drug delivery system for the treatment of bone metastasis","volume":"19","author":"Raichur","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0110","first-page":"331","article-title":"Development and in vitro\u2013in vivo evaluation of oral drug delivery system of acyclovir loaded PLGA nanoparticles","volume":"5","author":"Bhosale","year":"2013","journal-title":"Int. J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0115","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1773-2247(12)50095-X","article-title":"Multiunit floating drug delivery system of acyclovir: development, characterization and in vitro\u2013in vivo evaluation of spray-dried hollow microspheres","volume":"22","author":"Bhosale","year":"2012","journal-title":"J. Drug Del. Sci. Tech."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/02652048.2011.599437","article-title":"Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid","volume":"28","author":"Pourshahab","year":"2011","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0125","first-page":"1","article-title":"Synthesis, characterization and in-vitro antitubercular activity of isoniazid-gelatin conjugate","author":"Cassano","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2009.10.004","article-title":"Gelatin nanocarriers as potential vectors for effective management of tuberculosis","volume":"385","author":"Saraogi","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.01.035_rf0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijantimicag.2007.10.017","article-title":"Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles","volume":"31","author":"Ahmad","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.colsurfb.2012.12.008","article-title":"Isoniazid loaded core shell nanoparticles derived from PLGA\u2013PEG\u2013PLGA tri-block copolymers: in vitro and in vivo drug release","volume":"104","author":"Gajendiran","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0145","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/dkg477","article-title":"Poly(dl-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis","volume":"52","author":"Khuller","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2015.01.035_rf0115","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jac\/dkh260","article-title":"Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model","volume":"54","author":"Pandey","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tube.2004.11.003","article-title":"Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis","volume":"85","author":"Pandey","year":"2005","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jconrel.2015.01.035_rf0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2008.11.027","article-title":"One-step preparation of rifampicin\/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis","volume":"135","author":"Ohashi","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0165","first-page":"96","article-title":"Polymer nanoparticles for release of rifampicin","volume":"5","author":"Lacramioara","year":"2013","journal-title":"Am. Sci. Pub."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0170","first-page":"798","article-title":"Formulation and evaluation of isoniazid loaded-\u2211-polycaprolactone nanoparticles","volume":"5","author":"Behera","year":"2012","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0175","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijpharm.2007.05.062","article-title":"Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis","volume":"345","author":"Kisich","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0180","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1021\/bm049704h","article-title":"In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles","volume":"5","author":"Thomas","year":"2004","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2015.01.035_rf0150","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1021\/bc100354m","article-title":"Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages","volume":"21","author":"Kamat","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/370938","article-title":"Development of oral sustained release rifampicin loaded chitosan nanoparticles by design of experiment","author":"Patel","year":"2013","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0195","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/jac\/dkh411","article-title":"Lectin-functionalized poly(lactide-co-glycolide) nanoparticles as oral\/aerosolized antitubercular drug carriers for treatment of tuberculosis","volume":"54","author":"Sharma","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0200","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.nano.2012.02.015","article-title":"Nanoparticle-based adjuvant for enhanced protective efficacy of DNA vaccine Ag85A-ESAT-6-IL-21 against Mycobacterium tuberculosis infection","volume":"8","author":"Yu","year":"2012","journal-title":"Nanomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2015.01.035_rf0170","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1021\/mp200213r","article-title":"Mannose-functionalized \u201cpathogen-like\u201d polyanhydride nanoparticles target C-type lectin receptors on dendritic cells","volume":"8","author":"Carrillo-Conde","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/mp100203a","article-title":"Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery","volume":"8","author":"Park","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0215","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1016\/j.vaccine.2011.07.039","article-title":"Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis","volume":"29","author":"Ballester","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2004.03.008","article-title":"PLGA\u2013PEI nanoparticles for gene delivery to pulmonary epithelium","volume":"58","author":"Bivas-Benita","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0225","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1073\/pnas.0611430104","article-title":"Drying a tuberculosis vaccine without freezing","volume":"104","author":"Wong","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0230","article-title":"Nanotechnology and developing countries part 1: what possibilities?","volume":"1","author":"Maclurcan","year":"2005","journal-title":"AZoNano"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0235","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.mcp.2009.04.006","article-title":"A simple gold nanoparticle probes assay for identification of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex from clinical specimens","volume":"23","author":"Soo","year":"2009","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.jconrel.2015.01.035_rf0205","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1002\/anie.200901791","article-title":"Ultrasensitive detection of bacteria using core\u2013shell nanoparticles and an NMR-filter system","volume":"48","author":"Lee","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0245","doi-asserted-by":"crossref","DOI":"10.1063\/1.2431449","article-title":"Amorphous\/nanocrystalline silicon biosensor for the specific identification of unamplified nucleic acid sequences using gold nanoparticle probes","volume":"90","author":"Martins","year":"2007","journal-title":"Appl. Phys. Lett."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0250","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1016\/j.bios.2011.04.055","article-title":"Nanoparticle based DNA biosensor for tuberculosis detection using thermophilic helicase-dependent isothermal amplification","volume":"26","author":"Torres-Chavolla","year":"2011","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0255","first-page":"17931","article-title":"Luminescence decay dynamics and trace biomaterials detection potential of surface-functionalized nanoparticles","volume":"112","author":"Cheng","year":"2008","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0260","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jconrel.2004.10.034","article-title":"Improving peptide-based assays to differentiate between vaccination and Mycobacterium bovis infection in cattle using nanoparticle carriers for adsorbed antigens","volume":"102","author":"Saleem","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0265","first-page":"328","article-title":"Tuberculosis: what we don't know can, and does, hurt us","author":"Russel","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0270","series-title":"Current Diagnosis & Treatment in Pulmonary Medicine","author":"Hanley","year":"2014"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0275","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1749-6632.2001.tb11366.x","article-title":"Drug resistant tuberculosis in Africa","volume":"953","author":"Mwinga","year":"2001","journal-title":"Acad. Sci."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0280","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/bmj.325.7375.1282","article-title":"Current medical treatment for tuberculosis","volume":"325","author":"Chan","year":"2002","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0285","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJM199309093291108","article-title":"Treatment of multidrug-resistant tuberculosis","volume":"329","author":"Iseman","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2015.01.035_rf0240","first-page":"157","article-title":"Scientific basis of directly observed treatment, short course (DOTS)","volume":"101","author":"Sharma","year":"2003","journal-title":"J. Indian Med. Assoc."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/19.1.1","article-title":"Multiple drug resistant tuberculosis","volume":"19","author":"Jacaban","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0300","first-page":"105","article-title":"Factors associated with drug resistance in pulmonary tuberculosis","volume":"45","author":"Johnson","year":"2003","journal-title":"Indian J. Chest Dis. Allied Sci."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0305","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1101\/gr.166401","article-title":"Comparing genomes within the species Mycobacterium tuberculosis","volume":"11","author":"Kato-Maeda","year":"2001","journal-title":"Genome Res."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0310","first-page":"354","article-title":"Multidrug-resistant tuberculosis","volume":"120","author":"Sharma","year":"2004","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.jconrel.2015.01.035_rf0265","first-page":"121","article-title":"MDR TB: current status","volume":"52","author":"Prasad","year":"2005","journal-title":"Indian J. Tuberc."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0320","first-page":"43","article-title":"Health-systems efficiency in the Russian Federation: tuberculosis control","volume":"84","author":"Floyd","year":"2006","journal-title":"Bull. WHO"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0325","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0012-3692(15)50981-1","article-title":"Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control","volume":"130","author":"Sharma","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2228-5326-2-33","article-title":"Improved antimycobacterial activity of rifampin using solid lipid nanoparticles","volume":"2","author":"Aboutaleb","year":"2012","journal-title":"Int. Nano Lett."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0335","first-page":"398","article-title":"Kinetics and drug release studies of isoniazid encapsulated with PLA-Co-PEG\/Gold nanoparticles","volume":"4","author":"Raj","year":"2012","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0340","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/jac\/dkl128","article-title":"Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model","volume":"57","author":"Pandey","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-013-1634-1","article-title":"Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles","volume":"15","author":"Chuan","year":"2013","journal-title":"J. Nanoparticle Res."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0350","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/1061186X.2010.492522","article-title":"Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis","volume":"19","author":"Saraogi","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0355","first-page":"4597","article-title":"Relative study between isoniazid loaded chitosan with the gold encapsulated with isoniazid loaded chitosan nanoparticles","volume":"3","author":"Radha","year":"2013","journal-title":"Indo Am. J. Pharm. Res."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0360","first-page":"1256","article-title":"Formulation and evaluation of solid lipid nanoparticles of water soluble drug: isoniazid","volume":"3","author":"Nair","year":"2011","journal-title":"J. Pharm. Sci. Res."},{"key":"10.1016\/j.jconrel.2015.01.035_rf0315","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.vaccine.2004.07.036","article-title":"A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity","volume":"23","author":"Derrick","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0370","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1016\/j.vaccine.2008.05.050","article-title":"The LTK63 adjuvant improves protection conferred by Ag85B DNA\u2013protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-\u03d2 response","volume":"26","author":"Palma","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2015.01.035_bb0375","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1128\/IAI.02086-05","article-title":"High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection","author":"Hervas-Stubbs","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0380","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1099\/vir.0.81956-0","article-title":"Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells","volume":"87","author":"Havenga","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jconrel.2015.01.035_bb0385","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1128\/JVI.00264-12","article-title":"Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic Caspase pathways, preventing efficient antigen presentation","volume":"86","author":"Guzman","year":"2012","journal-title":"J. Virol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T23:57:19Z","timestamp":1537919839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":77,"alternative-id":["S0168365915000851"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.01.035","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential of nanotechnology as a delivery platform against tuberculosis: Current research review","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}